All In Biotech

Drug Trial Radar · NCT06254612

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

A Multi-center, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Aug 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 497 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

497

Actual

Start

Mar 25, 2024

Primary completion

Jul 8, 2026

Study completion Jul 8, 2026

Sponsor

Lead sponsor
Sirtsei Pharmaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
Rho, Inc.
First posted
Feb 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.

Conditions

  • Major Depressive Disorder

Interventions

  • SP-624Drug

    Once daily oral administration of two capsules totaling 20 mg/day

  • PlaceboDrug

    Once daily oral administration of two matching placebo capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) total score.Time frame: Baseline to Week 4

Locations

50 sites in 1 country. Site status is shown where the registry gives one.

  • IMA Clinical Research

    Phoenix, Arizona

  • Noble Clinical Research

    Tucson, Arizona

  • SanRo Clinical Research Group

    Bryant, Arkansas

  • Clinical Innovations

    Bellflower, California

  • Sun Valley Research Center

    Imperial, California

  • Synergy San Diego

    Lemon Grove, California

  • Excell Research

    Oceanside, California

  • CiTrials

    Riverside, California

  • Collaborative Neuroscience Research

    Torrance, California

  • Sunwise Clinical Research

    Walnut Creek, California

  • Next Level Clinical Trials

    West Covina, California

  • MCB Clinical Research Centers

    Colorado Springs, Colorado

  • Clinical Neuroscience Solutions

    Jacksonville, Florida

  • Accel Clinical

    Lakeland, Florida

  • Segal Trials

    Lauderhill, Florida

  • Segal Trials - Miami Lakes

    Miami Lakes, Florida

  • Clinical Neuroscience Solutions

    Orlando, Florida

  • DMI Research

    Pinellas Park, Florida

  • Accelerated Enrollment Solutions

    Atlanta, Georgia

  • Velocity Clinical Research

    Meridian, Idaho

  • Revive Research Institute

    Elgin, Illinois

  • Tandem Clinical Research

    Marrero, Louisiana

  • Boston Clinical Trials

    Boston, Massachusetts

  • Neurobehavioral Medicine Group

    Bloomfield Hills, Michigan

  • Midwest Research Group

    Saint Charles, Missouri

  • Alivation Research

    Lincoln, Nebraska

  • IMA Clinical Research

    Las Vegas, Nevada

  • Redbird Research

    Las Vegas, Nevada

  • Center for Emotional Fitness

    Cherry Hill, New Jersey

  • CenExel HRI

    Marlton, New Jersey

  • IMA Clinical Research

    Albuquerque, New Mexico

  • Integrative Clinical Trials

    Brooklyn, New York

  • Pioneer Clinical Research

    New York, New York

  • Magnolia Clinical Research

    Cary, North Carolina

  • UNC Chapel Hill

    Chapel Hill, North Carolina

  • New Hope Clinical Research

    Charlotte, North Carolina

  • Velocity Clinical Research

    Beachwood, Ohio

  • Midwest Clinical Research Center

    Dayton, Ohio

  • North Star Medical Research

    Middleburg Heights, Ohio

  • Summit Headlands

    Portland, Oregon

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.